\
&
Contact us
\
&
Contact us
Check if partners from Armenia qualify for Horizon Europe funding
Scroll further to find out what this means exactly
Association to Horizon Europe is the closest form of international cooperation in Horizon Europe. Entities of Associated Countries can participate in the Horizon Europe calls under the same conditions as entities from the EU Member States and are therefore eligible for funding, unless specific limitations or conditions are laid down in the work programme and/or call topic text.
Not only EU neighbouring countries can apply for association, any country in the world with a strong research and innovation capacity that share common values with Europe can apply for association to Horizon Europe.
There are 4 categories of countries eligible for association with Horizon Europe:
Close to the start of the Association, transitional measures can be set in place, through which entities of these countries have to be included as beneficiaries in call topics. Details are mentioned in the Horizon Europe Programme Guide.
All details regarding country eligibility is compiled in the infosheet “International cooperation".
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
